These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8543502)
1. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. Schmutzhard E; Williams KJ; Vukmirovits G; Chmelik V; Pfausler B; Featherstone A J Antimicrob Chemother; 1995 Jul; 36 Suppl A():85-97. PubMed ID: 8543502 [TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. Klugman KP; Dagan R Antimicrob Agents Chemother; 1995 May; 39(5):1140-6. PubMed ID: 7625802 [TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Odio CM; Puig JR; Feris JM; Khan WN; Rodriguez WJ; McCracken GH; Bradley JS Pediatr Infect Dis J; 1999 Jul; 18(7):581-90. PubMed ID: 10440432 [TBL] [Abstract][Full Text] [Related]
5. [The role of meropenem in bacterial meningitis]. Fernández Viladrich P Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():57-61. PubMed ID: 9410071 [TBL] [Abstract][Full Text] [Related]
6. Carbapenems in serious infections: a risk-benefit assessment. Norrby SR Drug Saf; 2000 Mar; 22(3):191-4. PubMed ID: 10738843 [TBL] [Abstract][Full Text] [Related]
7. Meropenem versus Cefotaxime and Ampicillin as Empirical Antibiotic Treatment in Adult Bacterial Meningitis: a Quality Registry Study, 2008 to 2016. Brink M; Glimåker M; Sjölin J; Naucler P Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501148 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program. Ellis JM; Kuti JL; Nicolau DP Paediatr Drugs; 2006; 8(2):131-8. PubMed ID: 16608373 [TBL] [Abstract][Full Text] [Related]
9. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae. Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094 [TBL] [Abstract][Full Text] [Related]
10. Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage. Straussberg R; Harel L; Amir J Infection; 2001 Oct; 29(5):280-2. PubMed ID: 11688908 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of meropenem in experimental meningitis. Nairn K; Shepherd GL; Edwards JR J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501 [TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group. Schuler D J Antimicrob Chemother; 1995 Jul; 36 Suppl A():99-108. PubMed ID: 8543503 [TBL] [Abstract][Full Text] [Related]
15. Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis. Force E; Taberner F; Cabellos C; Ribes S; Domenech A; Tubau F; Viladrich PF; Gudiol F Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):685-90. PubMed ID: 18386085 [TBL] [Abstract][Full Text] [Related]
16. Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone. Le Turnier P; Tattevin P; Varon E; Duval X Antimicrob Agents Chemother; 2023 Apr; 67(4):e0001223. PubMed ID: 36880753 [No Abstract] [Full Text] [Related]
17. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. Badawy AA; Zaher TI; Sharaf SM; Emara MH; Shaheen NE; Aly TF World J Gastroenterol; 2013 Feb; 19(8):1271-7. PubMed ID: 23483064 [TBL] [Abstract][Full Text] [Related]
18. Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan. Morita A; Kamei S; Minami M; Yoshida K; Kawabata S; Kuroda H; Suzuki Y; Araki N; Iwasaki Y; Kobayashi R; Hayashi N; Hirayama T; Ochiai J; Ueda M; Yamagishi Y; Niwa J; Shindo K; Fukushima Y; Takita T; Sato T; Sato S; Mikamo H; Iwata S J Infect Chemother; 2014 Sep; 20(9):535-40. PubMed ID: 24882451 [TBL] [Abstract][Full Text] [Related]
19. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. Goldwater PN Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469 [TBL] [Abstract][Full Text] [Related]
20. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries? Duke T; Michael A; Mokela D; Wal T; Reeder J Arch Dis Child; 2003 Jun; 88(6):536-9. PubMed ID: 12765927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]